BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 28440069)

  • 1. Occult cancer-related first venous thromboembolism is associated with an increased risk of recurrent venous thromboembolism.
    Gran OV; Braekkan SK; Paulsen B; Skille H; Rosendaal FR; Hansen JB
    J Thromb Haemost; 2017 Jul; 15(7):1361-1367. PubMed ID: 28440069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recurrence and mortality after first venous thromboembolism in a large population-based cohort.
    Arshad N; Bjøri E; Hindberg K; Isaksen T; Hansen JB; Braekkan SK
    J Thromb Haemost; 2017 Feb; 15(2):295-303. PubMed ID: 27943560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hospital-related first venous thromboembolism and risk of recurrence.
    Bjøri E; Arshad N; Johnsen HS; Hansen JB; Braekkan SK
    J Thromb Haemost; 2016 Dec; 14(12):2368-2375. PubMed ID: 27589573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of cancer after anticoagulation in patients with unprovoked venous thromboembolism: an observational cohort study.
    Eischer L; Kammer M; Traby L; Kyrle PA; Eichinger S
    J Thromb Haemost; 2017 Jul; 15(7):1368-1374. PubMed ID: 28407356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Venous thromboembolism and subsequent permanent work-related disability.
    Braekkan SK; Grosse SD; Okoroh EM; Tsai J; Cannegieter SC; Naess IA; Krokstad S; Hansen JB; Skjeldestad FE
    J Thromb Haemost; 2016 Oct; 14(10):1978-1987. PubMed ID: 27411161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of incident myocardial infarction on the risk of venous thromboembolism: the Tromsø Study.
    Rinde LB; Lind C; Småbrekke B; Njølstad I; Mathiesen EB; Wilsgaard T; Løchen ML; Hald EM; Vik A; Braekkan SK; Hansen JB
    J Thromb Haemost; 2016 Jun; 14(6):1183-91. PubMed ID: 27061154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Omega-3 fatty acids predict recurrent venous thromboembolism or total mortality in elderly patients with acute venous thromboembolism.
    Reiner MF; Stivala S; Limacher A; Bonetti NR; Méan M; Egloff M; Rodondi N; Aujesky D; von Schacky C; Lüscher TF; Camici GG; Beer JH
    J Thromb Haemost; 2017 Jan; 15(1):47-56. PubMed ID: 27790827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unprovoked venous thromboembolism and subsequent cancer risk: a population-based cohort study.
    Sun LM; Chung WS; Lin CL; Liang JA; Kao CH
    J Thromb Haemost; 2016 Mar; 14(3):495-503. PubMed ID: 26748492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prothrombotic genotypes and risk of venous thromboembolism in occult cancer.
    Skille H; Paulsen B; Hveem K; Severinsen MT; Gabrielsen ME; Kristensen SR; Næss IA; Hindberg K; Tjønneland A; Brækkan SK; Hansen JB
    Thromb Res; 2021 Sep; 205():17-23. PubMed ID: 34237679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The long-term recurrence risk of patients with unprovoked venous thromboembolism: an observational cohort study.
    Kyrle PA; Kammer M; Eischer L; Weltermann A; Minar E; Hirschl M; Heinze G; Eichinger S
    J Thromb Haemost; 2016 Dec; 14(12):2402-2409. PubMed ID: 27696701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of recurrent venous thromboembolism in patients with HIV infection: A nationwide cohort study.
    Rokx C; Borjas Howard JF; Smit C; Wit FW; Pieterman ED; Reiss P; Cannegieter SC; Lijfering WM; Meijer K; Bierman W; Tichelaar V; Rijnders BJA;
    PLoS Med; 2020 May; 17(5):e1003101. PubMed ID: 32407386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Joint effects of prothrombotic genotypes and body height on the risk of venous thromboembolism: the Tromsø study.
    Horvei LD; Braekkan SK; Smith EN; Solomon T; Hindberg K; Frazer KA; Rosendaal FR; Hansen JB
    J Thromb Haemost; 2018 Jan; 16(1):83-89. PubMed ID: 29094466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. One-year adherence to warfarin treatment for venous thromboembolism in high-risk patients and its association with long-term risk of recurrent events.
    Chen SY; Wu N; Gulseth M; LaMori J; Bookhart BK; Boulanger L; Fields L; Schein J
    J Manag Care Pharm; 2013 May; 19(4):291-301. PubMed ID: 23627575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Red cell distribution width is associated with incident venous thromboembolism (VTE) and case-fatality after VTE in a general population.
    Ellingsen TS; Lappegård J; Skjelbakken T; Brækkan SK; Hansen JB
    Thromb Haemost; 2015 Jan; 113(1):193-200. PubMed ID: 25274492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of recurrent venous thromboembolism and major hemorrhage in cancer-associated incidental pulmonary embolism among treated and untreated patients: a pooled analysis of 926 patients.
    van der Hulle T; den Exter PL; Planquette B; Meyer G; Soler S; Monreal M; Jiménez D; Portillo AK; O'Connell C; Liebman HA; Shteinberg M; Adir Y; Tiseo M; Bersanelli M; Abdel-Razeq HN; Mansour AH; Donnelly OG; Radhakrishna G; Ramasamy S; Bozas G; Maraveyas A; Shinagare AB; Hatabu H; Nishino M; Huisman MV; Klok FA
    J Thromb Haemost; 2016 Jan; 14(1):105-13. PubMed ID: 26469193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physical activity and risk of recurrence and mortality after incident venous thromboembolism.
    Evensen LH; Isaksen T; Braekkan SK; Hansen JB
    J Thromb Haemost; 2019 Jun; 17(6):901-911. PubMed ID: 30985982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment with dabigatran or warfarin in patients with venous thromboembolism and cancer.
    Schulman S; Goldhaber SZ; Kearon C; Kakkar AK; Schellong S; Eriksson H; Hantel S; Feuring M; Kreuzer J
    Thromb Haemost; 2015 Jul; 114(1):150-7. PubMed ID: 25739680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term risk of venous thromboembolism recurrence after isolated superficial vein thrombosis.
    Galanaud JP; Sevestre MA; Pernod G; Kahn SR; Genty C; Terrisse H; Brisot D; Gillet JL; Quéré I; Bosson JL
    J Thromb Haemost; 2017 Jun; 15(6):1123-1131. PubMed ID: 28317330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of D-Dimer for Prediction of Incident Occult Cancer in Patients with Unprovoked Venous Thromboembolism.
    Han D; ó Hartaigh B; Lee JH; Cho IJ; Shim CY; Chang HJ; Hong GR; Ha JW; Chung N
    PLoS One; 2016; 11(4):e0153514. PubMed ID: 27073982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet count measured prior to cancer development is a risk factor for future symptomatic venous thromboembolism: the Tromsø Study.
    Jensvoll H; Blix K; Brækkan SK; Hansen JB
    PLoS One; 2014; 9(3):e92011. PubMed ID: 24642868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.